Invasiveness-signal-quality tradeoff

The invasiveness-signal-quality tradeoff is the organising axis of this field: as an interface moves from scalp to intracranial to intracortical, it gains bandwidth, spatial resolution, and signal-to-noise, but incurs greater surgical risk, foreign-body response, and long-term instability. Scalp EEG and fNIRS are safe but blurred and band-limited; ECoG sits closer with better resolution; penetrating microelectrodes resolve single units but provoke gliosis and degrade over time.

Emerging and minimally invasive technologies are attempts to bend this curve, obtaining more of the signal for a given level of risk (endovascular arrays, on-scalp OPM-MEG, functional ultrasound). The honest framing for a graduate reader is that there is no free lunch: each technology occupies a region of a multi-objective space (bandwidth, resolution, depth, risk, durability, cost, portability), and the right choice is set by the clinical or scientific requirement, not by a single figure of merit.